The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating tumor DNA in the surveillance of patients with oligometastatic renal cell carcinoma treated with stereotactic ablative radiation.
 
Young Suk Suk Kwon
No Relationships to Disclose
 
Laurentiu Pop
No Relationships to Disclose
 
Maggie Janell Stein
No Relationships to Disclose
 
Alana Christie
No Relationships to Disclose
 
Subrata Manna
No Relationships to Disclose
 
Aurelie Garant
Honoraria - Intellisphere
Research Funding - Reflexion Medical (Inst); Teleflex Medical (Inst)
 
Daniel X. Yang
No Relationships to Disclose
 
Neil B Desai
No Relationships to Disclose
 
James Brugarolas
Consulting or Advisory Role - Exelixis; Johnson & Johnson; Telix Pharmaceuticals
Patents, Royalties, Other Intellectual Property - U.S. Application Number: 17/153,128 “PET RADIOPHARMACEUTICALS FOR NON-INVASIVE EVALUATION OF HIF-2alpha” (Inst); U.S. Application Number: 17/206,895 “BIOMARKERS OF RESPONSE TO HIF-2alpha INHIBITION IN CANCER AND METHODS FOR THE USE THEREOF” (Inst); U.S. Patent: US 11,576,889 B2 "METHODS OF IDENTIFYING AND TREATING PATIENTS WITH HIF-2 INHIBITOR RESISTANCE" (Inst)
 
Robert D. Timmerman
Consulting or Advisory Role - ImmuneSensor Therapeutics; Reflexion Medical
Research Funding - Accuray (Inst); Elekta (Inst); Varian Medical Systems (Inst)
 
Raquibul Hannan
No Relationships to Disclose